What is Serotonin Syndrome

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Serotonin Syndrome (PRESS Syndrome)

Serotonin syndrome is a potentially life-threatening condition characterized by excessive serotonergic activity in the nervous system, manifesting as a triad of mental status changes, autonomic instability, and neuromuscular hyperactivity. 1, 2

Definition and Pathophysiology

Serotonin syndrome occurs due to excessive serotonin stimulation in the central and peripheral nervous system, typically resulting from:

  • Use of a single serotonergic agent at high doses
  • Inadvertent interactions between multiple serotonergic medications
  • Combination of serotonergic agents with monoamine oxidase inhibitors (MAOIs)
  • Intentional or unintentional overdose of serotonergic medications 3

Clinical Presentation

The classic triad of symptoms includes:

  1. Mental Status Changes:

    • Agitation
    • Confusion
    • Delirium
    • Hallucinations
  2. Autonomic Instability:

    • Hyperthermia (temperature >38°C)
    • Tachycardia
    • Hypertension
    • Diaphoresis
    • Flushing
  3. Neuromuscular Abnormalities:

    • Tremor
    • Muscle rigidity
    • Hyperreflexia
    • Clonus (spontaneous, inducible, or ocular)
    • Myoclonus 1, 2

Diagnostic Criteria

The Hunter Serotonin Toxicity Criteria are the diagnostic standard, requiring:

  • Patient has taken a serotonergic drug within the past 5 weeks
  • At least ONE of the following:
    • Spontaneous clonus
    • Inducible clonus PLUS agitation or diaphoresis
    • Ocular clonus PLUS agitation or diaphoresis
    • Tremor AND hyperreflexia
    • Hypertonia AND temperature >38°C AND ocular or inducible clonus 1, 2

Common Causative Agents

  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Tricyclic Antidepressants (TCAs)
  • Opioids (particularly tramadol, meperidine)
  • Certain antibiotics (linezolid)
  • Over-the-counter medications containing dextromethorphan
  • Herbal supplements (St. John's Wort) 3, 4

Management

  1. Immediate discontinuation of all serotonergic agents - this is the most critical first step 1

  2. Supportive care:

    • IV fluid administration
    • External cooling for hyperthermia
    • Cardiac monitoring
    • Respiratory support if needed 1
  3. Pharmacological interventions:

    • Benzodiazepines for agitation and tremor
    • Cyproheptadine (a serotonin antagonist) for moderate to severe cases
    • Severe cases may require neuromuscular paralysis, sedation, and intubation 1, 2

Severity and Prognosis

  • Mild cases: Resolve with discontinuation of offending agents and supportive care
  • Moderate to severe cases: Require hospitalization and more aggressive management
  • Mortality rate: Approximately 11% for untreated cases 1
  • Potential complications: Rhabdomyolysis, renal failure, disseminated intravascular coagulation, seizures, and death 1

Differentiation from Similar Conditions

Serotonin syndrome must be differentiated from neuroleptic malignant syndrome (NMS), which presents similarly but is caused by dopamine antagonism rather than serotonin excess. Key differences:

  • NMS typically develops more slowly (days to weeks)
  • NMS features more prominent "lead-pipe" rigidity
  • NMS lacks the clonus and hyperreflexia characteristic of serotonin syndrome 1, 5

Prevention

Serotonin syndrome is highly preventable through:

  • Careful medication reconciliation
  • Avoiding combinations of serotonergic agents
  • Particular caution when prescribing MAOIs with other serotonergic medications
  • Patient education about potential drug interactions 3, 4

Special Considerations

In patients with underlying movement disorders like Parkinson's disease, diagnosis can be challenging as tremor may be attributed to the underlying condition rather than serotonin syndrome. A high index of suspicion is essential in these patients when serotonergic medications are involved 6.

References

Guideline

Neuroleptic Malignant Syndrome and Serotonin Syndrome Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Overview of serotonin syndrome.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2012

Research

Serotonin syndrome.

Annals of emergency medicine, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.